Dr. Mirela Andrei, MD

Dr. Andrei practices at Medical Oncology Associates, P.S. in Spokane Valley, Washington.

Dr. Andrei's NPI, 1578875225, was assigned on July 10, 2010. Dr. Andrei holds Washington license MD61025065.

Dr. Andrei's primary practice is Medical Oncology Associates, P.S., at 13424 E Mission Ave, Spokane Valley, WA 99216 in Spokane County. The practice phone is (509) 462-2273.

Dr. Andrei's primary practice is Medical Oncology Associates, P.S. in Spokane Valley, Washington. Dr. Andrei is also affiliated with MultiCare Deaconess Hospital. The medical group on file is Medical Oncology Associates. Dmand AI also links Dr. Andrei to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Andrei practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Andrei's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Andrei is licensed in Washington.

CMS data shows 44,144 Medicare services from Dr. Andrei across 37 procedure codes in 2024, for 624 Medicare patients. Medicare paid $993,707 for them.

CMS counts 624 Medicare patients who saw Dr. Andrei in 2024. The largest group is 75 to 84, with 262 patients. 68% of them have high blood pressure, and 68% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Andrei's median patient age at 72, with 60% women.

In 2024, Dr. Andrei wrote 792 Medicare Part D claims for 152 patients. 69% of them were for generic drugs. CMS names the drug for 580 of them, across 20 drugs with 11 or more claims each, at $1,516,822 in total drug cost. In 2023, CMS named 516 claims across 21 drugs.

Dr. Andrei accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Andrei, published from 2012 to 2019. 2016 was the busiest year, with 2. The most frequent topics are Neoplasm Proteins. Dr. Andrei's most frequent co-authors are Ajay Kundra, MD, Hemant Sindhu, MD and Cherif Hani Abdelmalek, MD.

CMS Open Payments shows 1,142 general payments to Dr. Andrei from 97 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,527.